Azor

Pharma

Daiichi Sankyo relinquishes rights to 8 cardio drugs to Cosette

In its effort to diversify, Cosette Pharma of New Jersey has acquired the U.S. rights to eight aging cardiovascular drugs from Daiichi Sankyo.

Kevin Dunleavy Jan 18, 2022 7:35am

Daiichi Sankyo

Daiichi Sankyo offers $300M to settle 2,300 Benicar lawsuits

Aug 1, 2017 5:25pm